News
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Restatement of Financial Statements and Postponement of the 2025 Annual Meeting; Restatement not expected to materially change financials in the Q1/2025 Preliminary Earnings Release
ADTRAN Holdings, Inc. announces restatement of financial statements for 2024 and 2023, postpones 2025 Annual Meeting. Impact assessed on consolidated financials. Preliminary Earnings Release details -
-
-
-
COMMUNIQUÉ DE PRESSE
Avino Achieves Another Quarter of Record Financial Performance for Q1 2025
Avino Silver & Gold Mines Ltd. announces record financial results for Q1 2025, with $5.6M net income, $18.8M revenues and $31.3M working capital. Strong operational performance and growth plans highlighted -
-
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Autres communiqués
GenSight Biologics annonce l’approbation de l’ensemble des résolutions soutenues par le Conseil d’Administration lors de son assemblée générale mixte du 13 mai 2025. La société biopharmaceutique GenSight Biologics se concentre sur le développement de thérapies géniques pour les maladies neurodégénératives
